Revolution Medicines (RVMDW) Revenue (2019 - 2023)
Revolution Medicines (RVMDW) posted quarterly Revenue of $742000.0 for Q4 2023, down 95.16% year-over-year from $15.3 million in Q4 2022, and down 80.6% quarter-over-quarter from $3.8 million in Q2 2023.
Revolution Medicines (RVMDW) Revenue (2019 - 2023) Analysis & Trends
Revolution Medicines' Revenue history runs 5 years deep, the most recent figure standing at $742000.0 for Q4 2023.
- In Q4 2023, Revenue fell 95.16% year-over-year to $742000.0; the TTM figure through Sep 2024 stood at $742000.0 (down 97.16% YoY), while the FY2023 annual figure was $11.6 million, down 67.27% from the prior year.
- Revenue for Q4 2023 stood at $742000.0, down from $3.8 million in the prior quarter.
- The five-year high for Revenue was $15.3 million in Q4 2022, with the low at $742000.0 in Q4 2023.
- The 5-year median for Revenue is $9.5 million (2021), against an average of $8.9 million.
- The sharpest annual moves came in 2022 and 2023: Revenue surged 204.81% in 2022, then tumbled 95.16% in 2023.
- Revolution Medicines' Revenue stood at $12.1 million in 2019, then fell by 27.61% to $8.8 million in 2020, then gained by 8.1% to $9.5 million in 2021, then surged by 62.05% to $15.3 million in 2022, then sank by 95.16% to $742000.0 in 2023.
- Business Quant data shows RVMDW's Revenue at $742000.0 in Q4 2023, $3.8 million in Q2 2023, and $7.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Revolution Medicines | 2.59 Bn | 2.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 742,000.00 |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 7.01 Mn |
| Dec 31, 2022 | 15.33 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 9.12 Mn |
| Mar 31, 2022 | 7.58 Mn |
| Dec 31, 2021 | 9.46 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 8.70 Mn |
| Mar 31, 2021 | 10.13 Mn |
| Dec 31, 2020 | 8.75 Mn |
| Sep 30, 2020 | 12.66 Mn |
| Jun 30, 2020 | 10.03 Mn |
| Mar 31, 2020 | 11.55 Mn |
| Dec 31, 2019 | 12.09 Mn |
| Sep 30, 2019 | 12.51 Mn |
| Jun 30, 2019 | 12.28 Mn |
| Mar 31, 2019 | 13.17 Mn |